FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) has introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity. The new BD Effivax Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) has announced the start of enrollment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). BD is a pioneer in DCB technology as the first to gain U.S. FDA approval for a paclitaxel DCB. BD’s Lutonix, which received FDA approval in 2014, is celebrating
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) and Frazier Healthcare Partners, a leading private equity firm focused exclusively on the health care sector, announced on Monday a definitive agreement for BD to acquire Parata Systems, an innovative provider of pharmacy automation solutions, for $1.525 billion. Parata’s portfolio of innovative pharmacy automation solutions power
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced that it has been named to Newsweek’s inaugural list of “America’s Most Trusted Companies” in the Health Care and Life Sciences category. The ranking takes into consideration three core audiences of trust including customer, investor and employee trust. BD is one of only three medical technology
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced the BD Veritor At-Home COVID-19 Test is now available for purchase through Everly Health, a digital health company at the forefront of the virtual diagnostics-driven care industry, and Southeastern Grocers, parent company of Fresco y Más, Harveys Supermarket, and Winn-Dixie stores, a leading grocery store
STAMFORD, Conn. – The global medical technology company, BD (Becton, Dickinson and Co.), has committed $500,000 to improve quality of care and reduce health inequities for patients served by free and charitable clinics across the United States. The New Jersey-based company will award $250,000 annually for the next two years to the health-focused relief organization Americares
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Co.) announced Thursday that it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead to varicose veins. CVI represents a significant and growing therapeutic need within the
